Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengde Wu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Translational Cancer Research|February 4, 2022
Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axisChengde Wu, Wei Lin, Fangyong Fu
Evidence-Based Complementary and Alternative Medicine : Ecam|August 15, 2022
Effect of Shenqi Fuzheng Injection on Leukopenia and T-cell Subsets in Patients with Non-small Cell Lung Cancer Undergoing RadiotherapyChengde Wu, Ying Liang, Fangyong Fu
Evidence-Based Complementary and Alternative Medicine : Ecam|April 24, 2023
Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung CancerYanxing Zhu, Zhiren Lin, Chengde Wu
Cancer Medicine|December 14, 2020
Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinomaChengde Wu, Xiang Rao, Wei Lin
Journal of Chemical Information and Modeling|November 28, 2006
Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretionJunmei Wang, George Krudy, Xiang-Qun Xie, et al.
Idrugs : the Investigational Drugs Journal|June 6, 2003
Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonistsChengde Wu, George W Holland, Tommy A Brock, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Nonpeptide endothelin antagonists in clinical developmentChengde Wu, E. Radford Decker, George W. Holland, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Discovery of 3-Quinazolin-4(3<i>H</i>)-on-3-yl-2,<i>N</i>-dimethylpropanamides as Orally Active and Selective PI3Kα InhibitorsJiaqiang Dong, Jingjie Huang, Ji Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2018
Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity modelTao Yu, Chengde Wu, NengYang Shih, et al.
Journal of Medicinal Chemistry|September 3, 2010
Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5Douglas F Burdi, Rachel Hunt, Lei Fan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Translational Cancer Research|February 4, 2022
Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axisChengde Wu, Wei Lin, Fangyong Fu
Evidence-Based Complementary and Alternative Medicine : Ecam|August 15, 2022
Effect of Shenqi Fuzheng Injection on Leukopenia and T-cell Subsets in Patients with Non-small Cell Lung Cancer Undergoing RadiotherapyChengde Wu, Ying Liang, Fangyong Fu
Evidence-Based Complementary and Alternative Medicine : Ecam|April 24, 2023
Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung CancerYanxing Zhu, Zhiren Lin, Chengde Wu
Cancer Medicine|December 14, 2020
Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinomaChengde Wu, Xiang Rao, Wei Lin
Journal of Chemical Information and Modeling|November 28, 2006
Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretionJunmei Wang, George Krudy, Xiang-Qun Xie, et al.
Idrugs : the Investigational Drugs Journal|June 6, 2003
Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonistsChengde Wu, George W Holland, Tommy A Brock, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Nonpeptide endothelin antagonists in clinical developmentChengde Wu, E. Radford Decker, George W. Holland, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Discovery of 3-Quinazolin-4(3<i>H</i>)-on-3-yl-2,<i>N</i>-dimethylpropanamides as Orally Active and Selective PI3Kα InhibitorsJiaqiang Dong, Jingjie Huang, Ji Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2018
Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity modelTao Yu, Chengde Wu, NengYang Shih, et al.
Journal of Medicinal Chemistry|September 3, 2010
Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5Douglas F Burdi, Rachel Hunt, Lei Fan, et al.
Pageof 2